IN8bio, Inc. (INAB) · 10+ Years of Financial Ratios

Profitability	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-146.16	-77.65	-46.42	-75.79	-89.91
Return on Capital (%)	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	17.06	13.16	17.24	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -

Credit	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Debt	- -	- -	- -	2	6	5
ST Debt	- -	- -	- -	1	1	2
LT Debt	- -	- -	- -	2	4	3
Total Debt/EBITDA	- -	- -	-0.02	-0.17	-0.21	-0.18
Net Debt/EBITDA	2.62	0.12	2.1	2.67	0.66	0.76
Total Debt/EBIT	- -	- -	-0.02	-0.16	-0.21	-0.16
Net Debt/EBIT	2.49	0.12	2.08	2.53	0.64	0.7
EBITDA to Interest Expense	-136.29	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-190.36	- -	- -	- -	- -	- -
EBIT to Interest Expense	-143.14	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-73.72	-838.94	-86.26	-77.42	-185.26	-270.6
Long-Term Debt/Equity (%)	- -	- -	- -	4.67	19.73	13.55
Long-Term Debt/Capital (%)	- -	- -	- -	-5.89	-8.11	-3.91
Long-Term Debt/Total Assets (%)	- -	- -	- -	4.23	13.57	10.02
Total Debt/Equity (%)	- -	- -	0.95	6.31	25.84	19.62
Total Debt/Capital (%)	- -	- -	1.02	-7.96	-10.62	-5.67
Total Debt/Total Assets (%)	- -	- -	0.83	5.71	17.78	14.52
Net Debt to Equity	-107.38	176.3	-97.27	-96.96	-79.98	-85.34
Net Debt/Capital (%)	1,134.09	51.09	1,862.07	55.01	24.73	19.78
EBITDA	-2	-5	-8	-14	-27	-28
EBITDA-CapEx	-3	-5	-8	-14	-31	-28
Operating Income (Loss)	-2	-5	-9	-15	-29	-30

Liquidity	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Cash Ratio	11.91	0.94	7	16.41	3.12	3.95
Current Ratio	12.11	1.18	7.05	17.28	3.82	4.57
Quick Ratio	11.98	0.94	7	16.41	3.12	3.95
CFO/Avg Current Liab	- -	-9.01	-4.43	-5.6	-5.97	-4.16
Common Equity/Total Assets	-73.72	-838.94	-86.26	-77.42	-185.26	-270.6
Long-Term Debt/Equity (%)	- -	- -	- -	4.67	19.73	13.55
Long-Term Debt/Capital (%)	- -	- -	- -	-5.89	-8.11	-3.91
Long-Term Debt/Total Assets (%)	- -	- -	- -	4.23	13.57	10.02
Total Debt/Equity (%)	- -	- -	0.95	6.31	25.84	19.62
Total Debt/Capital (%)	- -	- -	1.02	-7.96	-10.62	-5.67
Total Debt/Total Assets (%)	- -	- -	0.83	5.71	17.78	14.52
CFO/Total Liabilities	-221.88	-325.27	-275.51	-334.38	-234.03	-266.07
CFO/CapEx	-3.66	-14.55	- -	-43.72	-6.51	-38.9
Altman's Z-Score	-1.21	-26.42	-1.66	11.12	-1.86	-1.87

Working Capital	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -

Enterprise Value	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Market Capitalization	- -	- -	- -	83	52	61
- Cash & Cash Equivalents	5	1	18	37	18	21
+ Preferred Equity and Hybrid Capital	9	9	35	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	2	6	5
Enterprise Value	4	8	17	48	39	45
Total Capital	5	-1	17	-30	-55	-86
Total Debt/Capital (%)	- -	- -	1.02	-7.96	-10.62	-5.67
Total Debt / EV	- -	- -	0.01	0.05	0.15	0.11
EV/Sales	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	44	44	42
Diluted Enterprise Value	4	8	17	9	32	26
EV per Share	0.63	0.88	0.88	2.57	1.6	1.04
TTM Sales	- -	- -	- -	- -	- -	- -
TTM EBITDA	-2	-5	-8	-14	-27	-28
TTM Operating Income	-2	-5	-9	-15	-29	-30
TTM Cash Flow to Firm	-3	-5	-7	-14	-24	-23
TTM Free Cash Flow to Firm	-2	-4	-7	-13	-20	-23

Multiples	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Price/Earnings	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-5.02	-1.95	-1.57
Price/Earnings High	- -	- -	- -	-6.74	-3.2	-3.1
Price/Earnings Low	- -	- -	- -	-2.99	-1.02	-0.69
Price/Book Value	- -	- -	- -	-2.53	-0.84	-0.67
Price/Book Value Average	- -	- -	- -	-4.24	-1.06	-0.75
Price/Book Value High	- -	- -	- -	-5.69	-1.74	-1.48
Price/Book Value Low	- -	- -	- -	-2.52	-0.56	-0.33
Price/Tangible Book Value	- -	- -	- -	2.17	2.28	2.46
Price/Tangible Book Value Average	- -	- -	- -	3.63	2.88	2.74
Price/Tangible Book Value High	- -	- -	- -	4.87	4.72	5.4
Price/Tangible Book Value Low	- -	- -	- -	2.16	1.51	1.2
Price/Sales	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	-3.25	-1.83	-1.82
Price/Cash Flow Average	- -	- -	- -	-5.45	-2.3	-2.02
Price/Cash Flow High	- -	- -	- -	-7.31	-3.78	-3.98
Price/Cash Flow Low	- -	- -	- -	-3.24	-1.21	-0.88
Price/Free Cash Flow	- -	- -	- -	-3.33	-2.16	-1.86
Price/Free Cash Flow Average	- -	- -	- -	-5.57	-2.72	-2.07
Price/Free Cash Flow High	- -	- -	- -	-7.48	-4.47	-4.08
Price/Free Cash Flow Low	- -	- -	- -	-3.32	-1.43	-0.91
EV/Sales	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-2.05	-1.67	-2.02	-7.5	-1.92	-1.87
EV/EBITDA High	-2.05	-1.67	-2.02	-10.91	-3.45	-4.25
EV/EBITDA Low	-2.05	-1.67	-2.02	-3.45	-0.8	-0.48
EV/EBIT	- -	- -	- -	- -	- -	- -
EV/EBIT Average	-1.95	-1.64	-2	-7.1	-1.85	-1.71
EV/EBIT High	-1.95	-1.64	-2	-10.33	-3.31	-3.9
EV/EBIT Low	-1.95	-1.64	-2	-3.26	-0.76	-0.44
Last Price	- -	- -	- -	4.41	2.1	1.42
High Price	- -	- -	- -	9.9	4.35	3.11
Low Price	- -	- -	- -	4.39	1.39	0.69
Enterprise Value	4	8	17	48	39	45
Enterprise Value Average	4	8	17	104	53	52
Enterprise Value High	4	8	17	151	94	118
Enterprise Value Low	4	8	17	48	22	13

Per Share Data Items	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Shares Outstanding	6	9	19	19	25	43
Diluted Weighted Avg Shares	6	9	19	10	21	30
Basic Weighted Avg Shares	6	9	19	10	21	30
Revenue per Share	- -	- -	- -	- -	- -	- -
EBITDA per Share	-0.31	-0.53	-0.44	-1.39	-1.31	-0.93
Operating Income per Share	-0.32	-0.54	-0.44	-1.47	-1.36	-1.02
Basic EPS, GAAP	-0.41	-0.63	-0.53	-1.47	-1.36	-1
Basic EPS from Cont Ops	-0.34	-0.55	-0.44	-1.47	-1.36	-1
Diluted EPS, GAAP	-0.41	-0.63	-0.53	-1.47	-1.36	-1
Diluted EPS from Cont Ops	-0.34	-0.55	-0.44	-1.47	-1.36	-1
Dividend per Share	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.45	-0.51	-0.37	-1.35	-1.15	-0.78
Free Cash Flow per Basic Share	-0.57	-0.55	-0.37	-1.39	-1.33	-0.8
Cash & Equivalents per Share	0.81	0.07	0.93	1.97	0.74	0.49
Book Value per Share	-0.7	-1.01	-0.93	-1.74	-2.49	-2.11
Tangible Book Value per Share	-0.69	-0.99	-0.85	2.03	0.92	0.58

IN8bio, Inc.

INAB US

1.00

1.00